WEST FEBRUARY 23RD-24TH, 2017 CONFERENCE CHAIRS CHAIR OF THE PLANNING COMMITTEE FAIRMOUNT PACIFIC RIM, VANCOUVER, BC RESERVE YOUR SPACE TODAY!

Transcription

1 WEST FEBRUARY 23RD-24TH, 2017 FAIRMOUNT PACIFIC RIM, VANCOUVER, BC CONFERENCE CHAIRS Sharlene Gill, BSc (Pharm), MD, MPH, FACP, FRCPC Medical Oncologist, BC Cancer Agency Vancouver Centre Associate Professor of Medicine Anil Abraham Joy, MD, FRCPC Professor of Oncology (Division of Medical Oncology), University of Edmonton Staff Medical Oncologist, Cross Cancer Institute, Edmonton CHAIR OF THE PLANNING COMMITTEE RESERVE YOUR SPACE TODAY! PLEASE CONTACT: Lucas Severin, Event Coordinator Dr. Jean Maroun MD FRCPC FRCP(UK) Professor of Medicine, University of Ottawa Education Committee Member, Canadian Oncology Society

2 Suite 378, 3219 Yonge Street Toronto, ON, M4N 3S1 November 4, 2016 Past Event Sponsors Alexion Pharmaceuticals Amgen Canada Inc Astellas Pharma AstraZeneca Canada Inc Bayer Inc Boehringer Ingelheim GmbH Bristol-Myers Squibb Canada Celgene Inc Eisai Limited Eli Lilly Canada Inc Genomic Health, Inc Gilead Sciences, Inc Janssen Inc Leo Pharma Inc Lundbeck Canada Inc Merck & Co., Inc Novartis AG Dear Industry Partner, On behalf of the Organizing Committee (Dr. Sharlene Gill, Dr. Anil Abraham Joy and Dr. Jean Maroun) and OncologyEducation.com, we would like to invite you to join us as a sponsor for the annual Best of Oncology West Conference at the Fairmount Pacific Rim in Vancouver on February 24th, This meeting will highlight the most clinically relevant achievements of 2016 for several different tumour sites, and the faculty will be drawn from some of the most influential oncologists across the globe, Chaired by Dr. Sharlene Gill and Dr. Anil Abraham Joy. Meeting Objectives: To discuss the pivotal oncology trials presented in the different disease sites; To review the current standard of care for key malignancies; To discuss the current controversies in the management of specific cancers. Benefit from numerous networking opportunities that allow you to meet face-to-face with oncology key opinion leaders and share updates on your latest products and service offerings. The Best of Oncology West Conference audience and faculty will draw from among some of the most influential oncologists across Canada. Please note that all sponsorship amounts will need to include HST (HST #: RT0001). All cheques should be made payable to CancerLink Ontario Inc. Payment should be sent by regular mail to Suite 378, 3219 Yonge Street, Toronto, ON, M4N 3S1, or we can arrange for direct deposit. Sponsorships are 100% due upon agreement in order to secure the spot. We value your partnership as a sponsor and we look forward to working with you. Don t hesitate to contact us if you have any questions. We look forward to seeing you in Vancouver! Sincerely, Pfizer Canada Inc Hoffmann-La Roche Ltd Sanofi Pasteur Limited Takeda Canada Inc Jason Hamburg, BSc., BEd. Managing Director Suite 378, 3219 Yonge Street Toronto, ON, M4N 3S1 2 facebook.com/oncologyeducation info@oncologyeducation.com

3 MEET THE ORGANIZING COMMITTEE Dr. Sharlene Gill, BSc (Pharm), MD, MPH, FACP, FRCPC Medical Oncologist, BC Cancer Agency Vancouver Centre Associate Professor of Medicine Vancouver Centre, and a leading medical expert specializing in the treatment of cancers of the GI system including colorectal cancer, pancreatic cancer, cancers of the stomach and esophagus, and liver cancers. Trained at the University of British Columbia, The Mayo Clinic and Harvard University, she has over 12 years of experience as an Academic Medical Oncologist, Associate Professor, Researcher and Educator in this field with numerous publications and speaking engagements to her credit. Anil Abraham Joy, MD, FRCPC Professor of Oncology (Division of Medical Oncology), University of Edmonton Staff Medical Oncologist, Cross Cancer Institute, Edmonton Dr. Joy obtained his Bachelor of Science Degree and Medical Doctorate from the University of Alberta. He is certified by the Royal College of Physicians and Surgeons of Canada as a specialist in Internal Medicine with sub-specialty certification in Medical Oncology. Dr. Joy is a Professor of Oncology (Division of Medical Oncology) at the University of Alberta and is a Staff Medical Oncologist at the Cross Cancer Institute, in Edmonton, Alberta. His primary clinical care interests include both Breast and Thoracic malignancies. He is actively involved in patient care, clinical research and medical education. Over the years he has served in various roles for the Medical Council of Canada (LMCC), as a grant reviewer to the Canadian Breast Cancer Foundation and National Cancer Institute of Canada (NCIC) / Canadian Cancer Society Research Institute (CCSR) and continues to serve on an ongoing basis as an ad hoc reviewer to various oncology journals/organizations. He is involved and serves in various capacities within the Canadian Cancer Trials Group (CCTG). Dr. Jean Maroun MD FRCPC FRCP(UK) Chair of the Planning Committee Professor of Medicine, University of Ottawa Education Committee Member, Canadian Oncology Society Dr. Maroun graduated from St. Joseph s University, Beirut, Lebanon. He completed his training in Internal Medicine in England where he obtained the M.R.C.P. (UK) in He specialized in Medical Oncology at the University of Ottawa and in the Department of Developmental Therapeutics at the M.D. Anderson Cancer Centre, Houston, Texas, USA. Dr. Maroun is a Professor of Medicine at the University of Ottawa and was nominated Fellow of the Royal College of Physicians of London, England in Until June 2002 Dr. Maroun was chair of Medical Oncology at the University of Ottawa and Head of Medical Oncology at the Ottawa Regional Cancer Centre and Ottawa Hospital. Dr. Maroun was chair of the Ontario Provincial Gastro-Intestinal Practice Guidelines Committee. He is a past President of the Canadian Oncology Societies and the Canadian Association of Medical Oncologists. Dr. Maroun has long experience in the management of GI malignancies and has been involved in clinical research into new drugs development and new combinations in the treatment of colorectal cancer. His clinical and basic research focus is on Thymidylate Synthase Inhibitors and other predictors for targeted therapy. Dr. Maroun has published extensively in peer reviewed journals and is involved provincially and nationally in numerous academic and research committees. twitter.com/onced linkedin.com/company/oncologyeducation-com 3

4 WEST FEBRUARY 23 RD -24 TH, 2017 FAIRMONT PACIFIC RIM VANCOUVER, BRITISH COLUMBIA TENTATIVE AGENDA FRIDAY, FEBRUARY 24 TH, :30 a.m. - 8:30 a.m. REGISTRATION 8:30 a.m. - 8:40 a.m. WELCOME ADDRESS FROM CHAIRS Drs. Sharlene Gill & Anil Abraham Joy 8:40 a.m. - 9:10 a.m. GU Prostate 9:10 a.m. - 9:40 a.m. GU Non Prostate 9:40 a.m. - 10:10 a.m. Gynecological Cancers 10:10 a.m. - 10:25 a.m. BREAK + EXHIBITS 10:25 a.m. - 10:55 a.m. Hematology 10:55 a.m. - 11:40 a.m. Lung Cancer 11:40 a.m. - 12:40 p.m. LUNCH + EXHIBITS 12:40 p.m. - 1:10 p.m. GI Colorectal 1:10 p.m. - 1:40 p.m. GI Non-Colorectal 1:40 p.m. - 1:55 p.m. BREAK + EXHIBITS 1:55 p.m. - 2:50 p.m. Debate - Medical Assistance in Dying 2:50 p.m. - 3:20 p.m. Melanoma 3:20 p.m. - 4:05 p.m. Breast Cancer 4:05 p.m. - 4:20 p.m. SUMMARY & CONCLUDING REMARKS Drs. Sharlene Gill & Anil Abraham Joy Visit:

5 SPONSORSHIP LEVELS WEST Sponsorship Entitlements PLEASE NOTE: Non-supporting industry partners who wish to attend any of Oncology Education conferences will be charged a registration fee of $1500 per attendee. Please add 13% HST to ALL sponsorship payments. BREAKFAST/LUNCH SYMPOSIUM SPONSOR $25,000 INCLUDES: Platinum ($17,500) Gold ($13,000) Bronze ($8,000) Acknowledgement of sponsorship level on conference Website Acknowledgement of sponsorship level on venue signage Acknowledgement of sponsorship level on all other documents 1 form of promotional material in delegate package 1 additional form of promotional material in delegate package 4 Complimentary full registrations 3 Complimentary full registrations 2 Complimentary full registrations Exhibit table (size to be confirmed by allowable venue space) Opportunity to sponsor breakfast or lunch symposium (or first refusal rights) Opportunity to have additional medical education booth + $4000 Additional Sponsor Badges Up to 2 additional badges may be purchased by any support level sponsor for $500/each. Logo display on lectern in presentation rooms 4 Complimentary tickets for Symposia Naming right of the Symposia Sponsor Signage at symposia venue Marketing services/collateral development Project/registration management Archiving on OncologyEducation.com Audience response systems AV services Meals IF YOU WOULD LIKE TO SPONSOR OR HAVE ANY QUESTIONS PLEASE CONTACT: Lucas Severin, Event Coordinator lucas@oncologyeducation.com Please make all cheques payable to CancerLink Ontario Inc. Suite 378, 3219 Yonge Street Toronto, ON, Canada M4N 3S1 HST #: RT0001 Suite 378, 3219 Yonge Street Toronto, ON, M4N 3S1 info@oncologyeducation.com facebook.com/oncologyeducation twitter.com/onced linkin.com/company/oncologyeducation-com

6 TERMS AND CONDITIONS 1. ALLOCATION OF EXHIBIT SPACE: OncologyEducation.com (OE) intends to allocate the selection of exhibit space for exhibitors booths on a first-come, first-served basis. OE reserves the right to make changes to the floor plan. 2. PAYMENT: Exhibitors shall make payments via check or credit card, payable in full to CancerLink Ontario Inc: Mail checks to: CancerLink Ontario, Inc. Suite 378, 3219 Yonge Street Toronto, ON, Canada M4N 3S1 Funds must be in CA dollars. Full payment must be received at time of application. 3. CANCELLATION OF CONTRACT: If cancellation is received by October 1st, 2016, a 50% refund will be credited. After that time, there shall be no refunds for cancellations. Exhibitor agrees that the total space rental fee for the cancelled space shall be retained or paid to OE. 4. ELIGIBLE EXHIBITS: OE reserves the right to determine eligibility of any company or product to participate in the exhibit. OE can refuse or revoke rental of exhibitor booth space to any company whose display of goods or services is not, in the opinion of OE, compatible with the character and objectives of the exhibit. In such event, this agreement shall terminate and OE shall refund all funds paid to it. 5. SUBLETTING OF EXHIBIT SPACE: Exhibitors may not assign, sublet, or share their exhibitor booth space to or with another business or firm. Should an article of a nonexhibiting firm be required for operation or demonstration in an exhibitor s display, identification of such article shall be limited to the usual and regular nameplates, imprint, or trademark under which same is sold in the general course of business. 6. AGREEMENT TO INDEMNIFY, HOLD HARMLESS, AND WAIVE: (a) Exhibitor agrees to make no claim of any nature whatsoever against OE and its affiliates, their directors, officers, agents, servants, employees, subsidiaries, successors and assigns, or any of them, except for specified claims: (1) arising directly from the gross negligence of OE or its employees acting within the scope of their employment, and (2) caused by circumstances under the control of OE. This waiver shall include, without limitations: (i) loss, damage, or injury to any property of the exhibitor by fire, theft, destruction, vandalism, or any other cause, except that loss or damage directly attributable to the gross negligence of OE or its employees; (ii) any injury to the exhibitor, its agents, or employees by any cause, except for such injury directly attributable to the gross negligence of OE or its employees; (iii) loss, damage, or injury to the exhibitor s business by reason of space location or the failure to provide space for the exhibit, or by any failure to hold the exhibit as scheduled, and waiver as to such loss or injury shall here include claims arising from the gross negligence of OE, its employees or agents; (iv) loss, damage, or injury to the exhibitor s business caused by fire, electrical service interruption, or any other interruptive occurrence, and waiver as to such loss, damage, or injury shall here include claims arising from the gross negligence of OE, its employees, or agents; and (v) all consequential commercial damages arising out of any aspect of this agreement, including those damages resulting from the gross negligence of OE and its affiliates, their directors, officers, agents, servants, employees, subsidiaries, successors, and assigns, or any of them. (b) The exhibitor shall indemnify and hold OE and its affiliates, their directors, officers, agents, servants, employees, subsidiaries, successors, and assigns, or any of them, harmless from and against any and all claims, penalties, damages, losses, costs, charges, and expenses whatsoever, including reasonable attorney s fees and costs arising out of the exhibitor s participation in the exhibit, except where such claims are directly attributable to the gross negligence of OE or its employees, including without limitation the following: (i) damage or injury to any person, persons, or property arising from or by reason of the occupation and use of the exhibit space; (ii) acts done or caused to be done by Exhibitor, its agents, employees, guests, or invitees; (iii) any breach by the exhibitor of its obligations hereunder; (iv) any loss, damage, or destruction to property of the exhibit facilities caused by the exhibitors, its agents, employees, guests, or invitees; and (v) any loss, theft, misappropriation or otherwise, or damage or destruction of any property of the exhibitor or its employees brought into the exhibit facility. (c) Exhibitor hereby agrees to waive the right of subrogation by its insurance carriers to recover losses sustained under its insurance contract for real and personal property, when permitted by its contracts with its carriers. The exhibitor understands that OE does not maintain insurance covering the exhibitor s property and it is the responsibility of the exhibitor to obtain such insurance. 7. BADGES: Badges will be required for entry into the exhibit hall at all times. Business cards are not to be used in exhibit badge holders. OE has the right to limit the total number of exhibitor credentials that may be included with each booth. 8. SECURITY: Exhibitors are responsible for the security of their exhibit. Exhibitors are solely responsible for securing all sensitive or valuable items. If insurance to cover the above is desired, it must be placed and paid for by the individual exhibitor. 9. ACCEPTANCE: This agreement shall be deemed accepted by OE when received by an authorized representative of OE, either in person or upon receipt by Mail or other delivery method and confirmed by OE with an Exhibitor Space Contract acceptance form specifying booth assignment. 10. OTHER REGULATIONS: Any and all matters not specifically covered by preceding rules and regulations shall be subject solely to the decision of show management. 11. ENTIRE AGREEMENT: The provisions contained herein constitute the entire agreement and supersede all previous communications, representations, and agreements either verbal or written, between the parties hereto with respect to the subject matter hereof. *Sponsorship information may be changed by OncologyEducation.com without prior notice and the new rates will apply only to sponsors who have not yet committed to support for the event.